SEC Form 4 · accession 0001013606-17-000011
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D McDermott
Officer — Chief Executive Officer · Director
Period of report
Jan 9, 2017
Accepted (ET)
Jan 10, 2017 · 2:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 9, 2017 | A | 108,538 | $0.00 | A | 667,508 | D | |
| Common StockF2 | Jan 9, 2017 | F | 20,588 | $5.71 | D | 646,920 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on September 11, 2012. 50% percent of the shares subject to this performance award vested pursuant the terms of this award.
- F2Shares sold on January 9, 2017 to satisfy statutory minimum tax withholding obligations related to shares vested on December 31, 2016. The Reporting Person made a withholding election on January 6, 2017.